197 related articles for article (PubMed ID: 28903449)
1. Association between metformin and the risk of gastric cancer in patients with type 2 diabetes mellitus: a meta-analysis of cohort studies.
Zhou XL; Xue WH; Ding XF; Li LF; Dou MM; Zhang WJ; Lv Z; Fan ZR; Zhao J; Wang LX
Oncotarget; 2017 Aug; 8(33):55622-55631. PubMed ID: 28903449
[TBL] [Abstract][Full Text] [Related]
2. Effect of Metformin on the Prognosis of Gastric Cancer Patients with Type 2 Diabetes Mellitus: A Meta-Analysis Based on Retrospective Cohort Studies.
Li L; Huang J; Huang T; Yao J; Zhang Y; Chen M; Shentu H; Lou H
Int J Endocrinol; 2023; 2023():5892731. PubMed ID: 36915376
[TBL] [Abstract][Full Text] [Related]
3. Relationship of Serum Adiponectin Levels and Metformin Therapy in Patients with Type 2 Diabetes.
Su JR; Lu ZH; Su Y; Zhao N; Dong CL; Sun L; Zhao SF; Li Y
Horm Metab Res; 2016 Feb; 48(2):92-8. PubMed ID: 26808583
[TBL] [Abstract][Full Text] [Related]
4. The effect of metformin on gastric cancer in patients with type 2 diabetes: a systematic review and meta-analysis.
Shuai Y; Li C; Zhou X
Clin Transl Oncol; 2020 Sep; 22(9):1580-1590. PubMed ID: 32060719
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular risk following metformin treatment in patients with type 2 diabetes mellitus: Results from meta-analysis.
Zhang K; Yang W; Dai H; Deng Z
Diabetes Res Clin Pract; 2020 Feb; 160():108001. PubMed ID: 31904444
[TBL] [Abstract][Full Text] [Related]
6. Metformin and risk of cancer among patients with type 2 diabetes mellitus: A systematic review and meta-analysis.
Zhang K; Bai P; Dai H; Deng Z
Prim Care Diabetes; 2021 Feb; 15(1):52-58. PubMed ID: 32605879
[TBL] [Abstract][Full Text] [Related]
7. Metformin Use Is Associated With Better Survival of Breast Cancer Patients With Diabetes: A Meta-Analysis.
Xu H; Chen K; Jia X; Tian Y; Dai Y; Li D; Xie J; Tao M; Mao Y
Oncologist; 2015 Nov; 20(11):1236-44. PubMed ID: 26446233
[TBL] [Abstract][Full Text] [Related]
8. Metformin therapy and risk of colorectal adenomas and colorectal cancer in type 2 diabetes mellitus patients: A systematic review and meta-analysis.
Liu F; Yan L; Wang Z; Lu Y; Chu Y; Li X; Liu Y; Rui D; Nie S; Xiang H
Oncotarget; 2017 Feb; 8(9):16017-16026. PubMed ID: 27926481
[TBL] [Abstract][Full Text] [Related]
9. Prospective study of Type 2 diabetes mellitus, anti-diabetic drugs and risk of prostate cancer.
Häggström C; Van Hemelrijck M; Zethelius B; Robinson D; Grundmark B; Holmberg L; Gudbjörnsdottir S; Garmo H; Stattin P
Int J Cancer; 2017 Feb; 140(3):611-617. PubMed ID: 27770555
[TBL] [Abstract][Full Text] [Related]
10. The association between metformin use and colorectal cancer survival among patients with diabetes mellitus: An updated meta-analysis.
Tian S; Lei HB; Liu YL; Chen Y; Dong WG
Chronic Dis Transl Med; 2017 Sep; 3(3):169-175. PubMed ID: 29063073
[TBL] [Abstract][Full Text] [Related]
11. Association of GCK -30G> a polymorphism with gestational diabetes mellitus and type 2 diabetes mellitus risk: a meta-analysis involving 18 case-control studies.
Yang S; Du Q
Genet Test Mol Biomarkers; 2014 May; 18(5):289-98. PubMed ID: 24520939
[TBL] [Abstract][Full Text] [Related]
12. Metformin use improves survival of diabetic liver cancer patients: systematic review and meta-analysis.
Ma SJ; Zheng YX; Zhou PC; Xiao YN; Tan HZ
Oncotarget; 2016 Oct; 7(40):66202-66211. PubMed ID: 27494848
[TBL] [Abstract][Full Text] [Related]
13. Associations of metformin therapy treatment with endometrial cancer risk and prognosis: A systematic review and meta-analysis.
Xie H; Li M; Zheng Y
Gynecol Oncol; 2024 Mar; 182():15-23. PubMed ID: 38246042
[TBL] [Abstract][Full Text] [Related]
14. Association of metformin and statin uses with the prognosis of colon cancer: a meta-analysis.
Xu Y; Che H; Liu J; Ye P
Eur J Cancer Prev; 2024 Jan; ():. PubMed ID: 38215022
[TBL] [Abstract][Full Text] [Related]
15. Effect of metformin on the mortality of colorectal cancer patients with T2DM: meta-analysis of sex differences.
Wang Y; Xiao J; Zhao Y; Du S; Du J
Int J Colorectal Dis; 2020 May; 35(5):827-835. PubMed ID: 32100113
[TBL] [Abstract][Full Text] [Related]
16. Reduced colorectal cancer incidence in type 2 diabetic patients treated with metformin: a meta-analysis.
Nie Z; Zhu H; Gu M
Pharm Biol; 2016 Nov; 54(11):2636-2642. PubMed ID: 27159666
[TBL] [Abstract][Full Text] [Related]
17. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
Tseng CH
Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
[TBL] [Abstract][Full Text] [Related]
18. Diabetes mellitus and incidence and mortality of gastric cancer: a meta-analysis.
Tian T; Zhang LQ; Ma XH; Zhou JN; Shen J
Exp Clin Endocrinol Diabetes; 2012 Apr; 120(4):217-23. PubMed ID: 22187293
[TBL] [Abstract][Full Text] [Related]
19. Metformin Use Is Associated with Reduced Incidence and Improved Survival of Endometrial Cancer: A Meta-Analysis.
Tang YL; Zhu LY; Li Y; Yu J; Wang J; Zeng XX; Hu KX; Liu JY; Xu JX
Biomed Res Int; 2017; 2017():5905384. PubMed ID: 28409158
[TBL] [Abstract][Full Text] [Related]
20. Metformin-inclusive sulfonylurea therapy reduces the risk of Parkinson's disease occurring with Type 2 diabetes in a Taiwanese population cohort.
Wahlqvist ML; Lee MS; Hsu CC; Chuang SY; Lee JT; Tsai HN
Parkinsonism Relat Disord; 2012 Jul; 18(6):753-8. PubMed ID: 22498320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
